Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APM NASDAQ:EQ CVE:TMG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPMAptorum Group$0.77-1.5%$0.89$0.65▼$4.47$4.93M0.33371,941 shs32,663 shsEQEquillium$3.02+2.4%$2.49$0.29▼$3.45$186.52M1.771.04 million shs417,384 shsTMGThermal Energy InternationalC$0.16C$0.16C$0.12▼C$0.20C$27.35M-0.694097118,342 shs7,756 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPMAptorum Group-1.48%-8.06%-10.10%-17.74%-23.55%EQEquillium+2.41%-0.95%+14.87%+60.69%+805.03%TMGThermal Energy International0.00%+3.23%+3.23%+14.29%+18.52%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPMAptorum Group$0.77-1.5%$0.89$0.65▼$4.47$4.93M0.33371,941 shs32,663 shsEQEquillium$3.02+2.4%$2.49$0.29▼$3.45$186.52M1.771.04 million shs417,384 shsTMGThermal Energy InternationalC$0.16C$0.16C$0.12▼C$0.20C$27.35M-0.694097118,342 shs7,756 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPMAptorum Group-1.48%-8.06%-10.10%-17.74%-23.55%EQEquillium+2.41%-0.95%+14.87%+60.69%+805.03%TMGThermal Energy International0.00%+3.23%+3.23%+14.29%+18.52%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPMAptorum Group 1.00SellN/AN/AEQEquillium 2.78Moderate Buy$7.57150.63% UpsideTMGThermal Energy International 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest APM, TMMG, TMG, EQ, and MIRI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/24/2026EQEquillium Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)6/4/2026APMAptorum Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/28/2026EQEquillium Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingStrong-Buy$7.005/28/2026EQEquillium Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$5.005/28/2026EQEquillium Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$12.005/28/2026EQEquillium Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$1.00 ➝ $6.005/20/2026APMAptorum Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/6/2026APMAptorum Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/23/2026EQEquillium OppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$7.004/17/2026EQEquillium Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$12.004/16/2026EQEquillium B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$6.00(Data available from 6/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPMAptorum GroupN/AN/AN/AN/A$2.17 per shareN/AEQEquillium$41.10M4.65N/AN/A$0.47 per share6.43TMGThermal Energy InternationalC$33.29M0.82C$0.02 per share7.50C$0.03 per share5.61Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPMAptorum Group-$1.36MN/AN/AN/AN/AN/AN/AN/AN/AEQEquillium-$22.40M-$0.32N/AN/AN/AN/A-61.43%-53.72%8/13/2026 (Estimated)TMGThermal Energy InternationalC$598.75KC$0.0122.86N/AN/A3.74%29.96%5.64%N/ALatest APM, TMMG, TMG, EQ, and MIRI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026Q1 2026EQEquillium-$0.04-$0.06-$0.02-$0.06N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAPMAptorum GroupN/AN/AN/AN/AN/AEQEquilliumN/AN/AN/AN/AN/ATMGThermal Energy InternationalN/A4.24%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPMAptorum GroupN/A0.780.78EQEquilliumN/A18.6218.62TMGThermal Energy International21.571.471.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPMAptorum Group3.80%EQEquillium27.05%TMGThermal Energy International0.11%Insider OwnershipCompanyInsider OwnershipAPMAptorum Group63.99%EQEquillium17.84%TMGThermal Energy International6.15%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPMAptorum Group306.35 million2.29 millionNot OptionableEQEquillium4063.23 million51.95 millionNot OptionableTMGThermal Energy InternationalN/A170.96 millionN/ANot OptionableAPM, TMMG, TMG, EQ, and MIRI HeadlinesRecent News About These CompaniesThermal Energy International to Present at Planet MicroCap Las VegasJune 9, 2026 | theglobeandmail.comThermal Energy International to Present at the 2026 Canadian Climate Investor ConferenceJune 3, 2026 | finance.yahoo.comBuy this Canadian microcap for a double, analyst saysMay 4, 2026 | cantechletter.comCThermal Energy Reports 62% Revenue Growth and Improved Profitability for the Third QuarterApril 29, 2026 | theglobeandmail.comThermal Energy International to Announce Third Quarter Results on April 28, 2026April 21, 2026 | finance.yahoo.comThermal Energy International to Participate in TSX-Sponsored European RoadshowApril 15, 2026 | finance.yahoo.comThermal Energy Wins $1 Million Turnkey Project --- Ninth with Global Nutrition CompanyFebruary 18, 2026 | theglobeandmail.comThis microcap stock is a buy, analyst saysJanuary 26, 2026 | cantechletter.comCThermal Energy International to Announce Second Quarter Results on January 27, 2026January 21, 2026 | finance.yahoo.comThermal Energy International Sets January 27 Date for Q2 2026 Results Release and Earnings CallJanuary 21, 2026 | tipranks.comThermal Energy Appoints Vincent Sands as Executive Vice PresidentJanuary 7, 2026 | theglobeandmail.comAnalyst loves this Canadian microcap stockDecember 24, 2025 | cantechletter.comCThermal Energy Receives $1.5 Million in Repeat Business from Multinational Building Materials CompanyDecember 17, 2025 | finance.yahoo.comThermal Energy secures $3.2 million heat recovery orderDecember 15, 2025 | msn.comThermal Energy Announces $3.2 Million Turnkey Heat Recovery Order from Leading Multinational Frozen Food CompanyDecember 15, 2025 | finance.yahoo.comThermal Energy International Grants Stock Options to Enhance Management IncentivesNovember 30, 2025 | tipranks.comThermal Energy International Inc. Receives an Additional $1.6 Million Order to Deliver Customized HeatSponge Heat Recovery Units to the ArcticNovember 20, 2025 | finance.yahoo.comThermal Energy Secures Major Arctic Heat Recovery ProjectNovember 20, 2025 | tipranks.comThermal Energy International Inc.: Thermal Energy Announces $1.5 Million in Repeat Business from Global Nutrition CompanyNovember 5, 2025 | finanznachrichten.deThermal Energy Announces $1.5 Million in Repeat Business from Global Nutrition CompanyNovember 5, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap SpaceBy Nathan Reiff | June 14, 2026Draining the Tank: Big Oil Runs on FumesBy Jeffrey Neal Johnson | June 17, 2026Alphabet's $80 Billion Offering: Worrisome Dilution or AI Confidence?By Ryan Hasson | June 2, 2026Wall Street Is Starting to Talk About Tesla's EndgameBy Sam Quirke | May 29, 2026If the Market Rally Stalls, This ETF Can Insulate PortfoliosBy Jessica Mitacek | May 28, 2026APM, TMMG, TMG, EQ, and MIRI Company DescriptionsAptorum Group NASDAQ:APM$0.76 -0.01 (-1.48%) Closing price 06/26/2026 03:50 PM EasternExtended Trading$0.78 +0.02 (+1.96%) As of 06/26/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A. The company is also developing ALS-2/3 for the treatment of gram+ve bacterial infections; RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, women's health, and other disease areas. In addition, it operates a medical clinic. The company was formerly known as APTUS Holdings Limited and changed its name to Aptorum Group Limited in October 2017. Aptorum Group Limited was incorporated in 2010 and is headquartered in London, the United Kingdom. Aptorum Group Limited is a subsidiary of Jurchen Investment Corporation.Equillium NASDAQ:EQ$3.02 +0.07 (+2.41%) Closing price 06/26/2026 03:59 PM EasternExtended Trading$2.98 -0.05 (-1.52%) As of 06/26/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a first-in-class monoclonal antibody that targets the immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase I clinical trial for the treatment of ulcerative colitis; and Phase I clinical trial for the treatment of lupus nephritis. It also develops EQ101 completed phase 1/2 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ302 to treat gastrointestinal indications. In addition, it serves dermatology, gastroenterology, rheumatology, hematology, transplant science, oncology, and pulmonology area. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.Thermal Energy International CVE:TMGC$0.16 0.00 (0.00%) As of 06/26/2026 09:30 AM EasternThermal Energy International Inc. engages in the development, engineering, and supply of pollution control products, heat recovery systems, and condensate return solutions in North America, Europe, and internationally. Its products include GEM steam traps; FLUACE, a direct contact condensing heat recovery system that recycles the heat lost through the boiler flue gas exhaust; DRY-REX, a low temperature biomass dryer; boiler feedwater economizer; vent condenser; boiler blowdown heat recovery; Heat Recovery Steam Generator; indirect contact condensing heat recovery; air to air heat exchange; and sofame products. It serves food and beverage, pulp and paper, hospital, pharmaceutical, chemicals and petrochemicals, and other industry sectors. Thermal Energy International Inc. was incorporated in 1991 and is based in Ottawa, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Rocket Lab's NASA Win Tests Key Support After Sharp Pullback BlackBerry’s Rally Is Running on a Bigger AI Story Than Earnings Alone Fabrinet Is Becoming a Quiet Winner in the AI Optics Buildout Palantir’s Valuation Problem Just Met 2 New Growth Catalysts Micron’s HBM Surge Could Redefine the AI Growth Story Carnival's Second Quarter: Is the Stock Still Complicated? Xcel Energy Stock Offers Stability as Electricity Demand Builds Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
